These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Industry updates from the field of stem cell research and regenerative medicine in February 2020. Ilic D; Liovic M Regen Med; 2020 Jun; 15(6):1689-1694. PubMed ID: 32290767 [TBL] [Abstract][Full Text] [Related]
63. Translational research and therapeutic applications of stem cell transplantation in periodontal regenerative medicine. Lu H; Xie C; Zhao YM; Chen FM Cell Transplant; 2013; 22(2):205-29. PubMed ID: 23031442 [TBL] [Abstract][Full Text] [Related]
64. Stem cell research shows promise for heart failure patients. Though it remains years away from wide clinical practice, stem cell therapy continues to offer encouraging glimpses at future heart disease care. Heart Advis; 2010 Dec; 13(12):3. PubMed ID: 23173222 [No Abstract] [Full Text] [Related]
65. Industry highlights: Stem cell and regenerative medicine. Ilic D Regen Med; 2011 Nov; 6(6 Suppl):55-60. PubMed ID: 21999262 [No Abstract] [Full Text] [Related]
67. Alan Trounson. Interview by Asher Mullard. Trounson A Nat Rev Drug Discov; 2012 Jun; 11(7):512. PubMed ID: 22699775 [No Abstract] [Full Text] [Related]
68. Is belief larger than fact: expectations, optimism and reality for translational stem cell research. Bubela T; Li MD; Hafez M; Bieber M; Atkins H BMC Med; 2012 Nov; 10():133. PubMed ID: 23131007 [TBL] [Abstract][Full Text] [Related]
69. Stem cell-based therapies: promises, obstacles, discordance, and the agora. Eggleson KK Perspect Biol Med; 2012; 55(1):1-25. PubMed ID: 22643713 [TBL] [Abstract][Full Text] [Related]
70. UK launches a new centre of excellence for stem cell research. Qadir Z Lancet; 2012 Aug; 380(9841):549. PubMed ID: 22891371 [No Abstract] [Full Text] [Related]
71. Current understanding and challenges in bioprocessing of stem cell-based therapies for regenerative medicine. Ratcliffe E; Thomas RJ; Williams DJ Br Med Bull; 2011; 100():137-55. PubMed ID: 21852279 [TBL] [Abstract][Full Text] [Related]
72. California institute to help stem-cell biotechs. Hayden EC Nature; 2008 Sep; 455(7212):436-7. PubMed ID: 18818612 [No Abstract] [Full Text] [Related]
73. Tech news: stem cells for modeling and curing disease. Leask F Biotechniques; 2018 Dec; 65(6):305-310. PubMed ID: 30477326 [TBL] [Abstract][Full Text] [Related]
74. Value-engineered translation for regenerative medicine: meeting the needs of health systems. Bubela T; McCabe C Stem Cells Dev; 2013 Dec; 22 Suppl 1(Suppl 1):89-93. PubMed ID: 24304083 [TBL] [Abstract][Full Text] [Related]
78. Advances in stem cells and regenerative medicine: single-cell dynamics, new models and translational perspectives. Twigger AJ; Scheel CH Development; 2017 Sep; 144(17):3007-3011. PubMed ID: 28851721 [TBL] [Abstract][Full Text] [Related]
79. The economic value of investing in regenerative medicine. Hussain A; Rivers PA J Health Care Finance; 2009; 36(2):45-54. PubMed ID: 20499720 [TBL] [Abstract][Full Text] [Related]